Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/ranbaxy-fined-500-m-for-flawed-generics-narayan-lakshman-21115/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/ranbaxy-fined-500-m-for-flawed-generics-narayan-lakshman-21115/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/ranbaxy-fined-500-m-for-flawed-generics-narayan-lakshman-21115/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/ranbaxy-fined-500-m-for-flawed-generics-narayan-lakshman-21115/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68047be589f85-trace').style.display = (document.getElementById('cakeErr68047be589f85-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68047be589f85-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68047be589f85-code').style.display = (document.getElementById('cakeErr68047be589f85-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68047be589f85-context').style.display = (document.getElementById('cakeErr68047be589f85-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68047be589f85-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr68047be589f85-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 20970,
		&#039;title&#039; =&gt; &#039;Ranbaxy fined $500 m for flawed generics-Narayan Lakshman&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &amp;quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &amp;quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While Ranbaxy was &amp;quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy&#039;s stakeholders,&amp;quot; he added.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Specifically, federal prosecutors said Ranbaxy USA Inc.&#039;s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government&#039;s allegations against Ranbaxy made &amp;quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Following several years of a federal investigation into Ranbaxy&#039;s alleged &amp;quot;manufacturing deficiencies,&amp;quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 15 May, 2013, http://www.thehindu.com/todays-paper/ranbaxy-fined-500-m-for-flawed-generics/article4716872.ece&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;ranbaxy-fined-500-m-for-flawed-generics-narayan-lakshman-21115&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21115,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 20970,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Ranbaxy fined $500 m for flawed generics-Narayan Lakshman&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,generic drugs&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu



Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &amp;quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &amp;quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While Ranbaxy was &amp;quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy&#039;s stakeholders,&amp;quot; he added.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Specifically, federal prosecutors said Ranbaxy USA Inc.&#039;s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government&#039;s allegations against Ranbaxy made &amp;quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Following several years of a federal investigation into Ranbaxy&#039;s alleged &amp;quot;manufacturing deficiencies,&amp;quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 20970,
	&#039;title&#039; =&gt; &#039;Ranbaxy fined $500 m for flawed generics-Narayan Lakshman&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &amp;quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &amp;quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While Ranbaxy was &amp;quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy&#039;s stakeholders,&amp;quot; he added.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Specifically, federal prosecutors said Ranbaxy USA Inc.&#039;s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government&#039;s allegations against Ranbaxy made &amp;quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Following several years of a federal investigation into Ranbaxy&#039;s alleged &amp;quot;manufacturing deficiencies,&amp;quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 15 May, 2013, http://www.thehindu.com/todays-paper/ranbaxy-fined-500-m-for-flawed-generics/article4716872.ece&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;ranbaxy-fined-500-m-for-flawed-generics-narayan-lakshman-21115&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21115,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 20970
$metaTitle = &#039;LATEST NEWS UPDATES | Ranbaxy fined $500 m for flawed generics-Narayan Lakshman&#039;
$metaKeywords = &#039;medicines,generic drugs&#039;
$metaDesc = &#039;
-The Hindu



Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &amp;quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &amp;quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While Ranbaxy was &amp;quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy&#039;s stakeholders,&amp;quot; he added.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Specifically, federal prosecutors said Ranbaxy USA Inc.&#039;s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government&#039;s allegations against Ranbaxy made &amp;quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Following several years of a federal investigation into Ranbaxy&#039;s alleged &amp;quot;manufacturing deficiencies,&amp;quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/ranbaxy-fined-500-m-for-flawed-generics-narayan-lakshman-21115.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Ranbaxy fined $500 m for flawed generics-Narayan Lakshman | Im4change.org</title>
    <meta name="description" content="
-The Hindu



Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Ranbaxy fined $500 m for flawed generics-Narayan Lakshman</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu</div><p align="justify"><br />Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.</p><p align="justify">The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&quot;</p><p align="justify">Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&quot;</p><p align="justify">While Ranbaxy was &quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy's stakeholders,&quot; he added.</p><p align="justify">Specifically, federal prosecutors said Ranbaxy USA Inc.'s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government's allegations against Ranbaxy made &quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&quot;</p><p align="justify">Following several years of a federal investigation into Ranbaxy's alleged &quot;manufacturing deficiencies,&quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.</p><p align="justify">In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.</p><p align="justify">In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68047be589f85-trace').style.display = (document.getElementById('cakeErr68047be589f85-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68047be589f85-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68047be589f85-code').style.display = (document.getElementById('cakeErr68047be589f85-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68047be589f85-context').style.display = (document.getElementById('cakeErr68047be589f85-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68047be589f85-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr68047be589f85-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 20970,
		&#039;title&#039; =&gt; &#039;Ranbaxy fined $500 m for flawed generics-Narayan Lakshman&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &amp;quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &amp;quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While Ranbaxy was &amp;quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy&#039;s stakeholders,&amp;quot; he added.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Specifically, federal prosecutors said Ranbaxy USA Inc.&#039;s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government&#039;s allegations against Ranbaxy made &amp;quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Following several years of a federal investigation into Ranbaxy&#039;s alleged &amp;quot;manufacturing deficiencies,&amp;quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 15 May, 2013, http://www.thehindu.com/todays-paper/ranbaxy-fined-500-m-for-flawed-generics/article4716872.ece&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;ranbaxy-fined-500-m-for-flawed-generics-narayan-lakshman-21115&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21115,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 20970,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Ranbaxy fined $500 m for flawed generics-Narayan Lakshman&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,generic drugs&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu



Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &amp;quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &amp;quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While Ranbaxy was &amp;quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy&#039;s stakeholders,&amp;quot; he added.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Specifically, federal prosecutors said Ranbaxy USA Inc.&#039;s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government&#039;s allegations against Ranbaxy made &amp;quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Following several years of a federal investigation into Ranbaxy&#039;s alleged &amp;quot;manufacturing deficiencies,&amp;quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 20970,
	&#039;title&#039; =&gt; &#039;Ranbaxy fined $500 m for flawed generics-Narayan Lakshman&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &amp;quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &amp;quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While Ranbaxy was &amp;quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy&#039;s stakeholders,&amp;quot; he added.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Specifically, federal prosecutors said Ranbaxy USA Inc.&#039;s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government&#039;s allegations against Ranbaxy made &amp;quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Following several years of a federal investigation into Ranbaxy&#039;s alleged &amp;quot;manufacturing deficiencies,&amp;quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 15 May, 2013, http://www.thehindu.com/todays-paper/ranbaxy-fined-500-m-for-flawed-generics/article4716872.ece&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;ranbaxy-fined-500-m-for-flawed-generics-narayan-lakshman-21115&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21115,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 20970
$metaTitle = &#039;LATEST NEWS UPDATES | Ranbaxy fined $500 m for flawed generics-Narayan Lakshman&#039;
$metaKeywords = &#039;medicines,generic drugs&#039;
$metaDesc = &#039;
-The Hindu



Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &amp;quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &amp;quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While Ranbaxy was &amp;quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy&#039;s stakeholders,&amp;quot; he added.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Specifically, federal prosecutors said Ranbaxy USA Inc.&#039;s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government&#039;s allegations against Ranbaxy made &amp;quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Following several years of a federal investigation into Ranbaxy&#039;s alleged &amp;quot;manufacturing deficiencies,&amp;quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/ranbaxy-fined-500-m-for-flawed-generics-narayan-lakshman-21115.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Ranbaxy fined $500 m for flawed generics-Narayan Lakshman | Im4change.org</title>
    <meta name="description" content="
-The Hindu



Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Ranbaxy fined $500 m for flawed generics-Narayan Lakshman</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu</div><p align="justify"><br />Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.</p><p align="justify">The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&quot;</p><p align="justify">Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&quot;</p><p align="justify">While Ranbaxy was &quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy's stakeholders,&quot; he added.</p><p align="justify">Specifically, federal prosecutors said Ranbaxy USA Inc.'s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government's allegations against Ranbaxy made &quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&quot;</p><p align="justify">Following several years of a federal investigation into Ranbaxy's alleged &quot;manufacturing deficiencies,&quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.</p><p align="justify">In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.</p><p align="justify">In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68047be589f85-trace').style.display = (document.getElementById('cakeErr68047be589f85-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68047be589f85-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68047be589f85-code').style.display = (document.getElementById('cakeErr68047be589f85-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68047be589f85-context').style.display = (document.getElementById('cakeErr68047be589f85-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68047be589f85-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr68047be589f85-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 20970,
		&#039;title&#039; =&gt; &#039;Ranbaxy fined $500 m for flawed generics-Narayan Lakshman&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &amp;quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &amp;quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While Ranbaxy was &amp;quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy&#039;s stakeholders,&amp;quot; he added.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Specifically, federal prosecutors said Ranbaxy USA Inc.&#039;s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government&#039;s allegations against Ranbaxy made &amp;quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Following several years of a federal investigation into Ranbaxy&#039;s alleged &amp;quot;manufacturing deficiencies,&amp;quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 15 May, 2013, http://www.thehindu.com/todays-paper/ranbaxy-fined-500-m-for-flawed-generics/article4716872.ece&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;ranbaxy-fined-500-m-for-flawed-generics-narayan-lakshman-21115&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21115,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 20970,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Ranbaxy fined $500 m for flawed generics-Narayan Lakshman&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,generic drugs&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu



Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &amp;quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &amp;quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While Ranbaxy was &amp;quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy&#039;s stakeholders,&amp;quot; he added.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Specifically, federal prosecutors said Ranbaxy USA Inc.&#039;s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government&#039;s allegations against Ranbaxy made &amp;quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Following several years of a federal investigation into Ranbaxy&#039;s alleged &amp;quot;manufacturing deficiencies,&amp;quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 20970,
	&#039;title&#039; =&gt; &#039;Ranbaxy fined $500 m for flawed generics-Narayan Lakshman&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &amp;quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &amp;quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
While Ranbaxy was &amp;quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy&#039;s stakeholders,&amp;quot; he added.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Specifically, federal prosecutors said Ranbaxy USA Inc.&#039;s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government&#039;s allegations against Ranbaxy made &amp;quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Following several years of a federal investigation into Ranbaxy&#039;s alleged &amp;quot;manufacturing deficiencies,&amp;quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 15 May, 2013, http://www.thehindu.com/todays-paper/ranbaxy-fined-500-m-for-flawed-generics/article4716872.ece&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;ranbaxy-fined-500-m-for-flawed-generics-narayan-lakshman-21115&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21115,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 20970
$metaTitle = &#039;LATEST NEWS UPDATES | Ranbaxy fined $500 m for flawed generics-Narayan Lakshman&#039;
$metaKeywords = &#039;medicines,generic drugs&#039;
$metaDesc = &#039;
-The Hindu



Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;Ranbaxy, one of India&#039;s largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &amp;quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &amp;quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;While Ranbaxy was &amp;quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy&#039;s stakeholders,&amp;quot; he added.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Specifically, federal prosecutors said Ranbaxy USA Inc.&#039;s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government&#039;s allegations against Ranbaxy made &amp;quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Following several years of a federal investigation into Ranbaxy&#039;s alleged &amp;quot;manufacturing deficiencies,&amp;quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/ranbaxy-fined-500-m-for-flawed-generics-narayan-lakshman-21115.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Ranbaxy fined $500 m for flawed generics-Narayan Lakshman | Im4change.org</title>
    <meta name="description" content="
-The Hindu



Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Ranbaxy fined $500 m for flawed generics-Narayan Lakshman</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu</div><p align="justify"><br />Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.</p><p align="justify">The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&quot;</p><p align="justify">Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&quot;</p><p align="justify">While Ranbaxy was &quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy's stakeholders,&quot; he added.</p><p align="justify">Specifically, federal prosecutors said Ranbaxy USA Inc.'s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government's allegations against Ranbaxy made &quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&quot;</p><p align="justify">Following several years of a federal investigation into Ranbaxy's alleged &quot;manufacturing deficiencies,&quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.</p><p align="justify">In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.</p><p align="justify">In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 20970,
		'title' => 'Ranbaxy fined $500 m for flawed generics-Narayan Lakshman',
		'subheading' => '',
		'description' => '<div align="justify">
-The Hindu
</div>
<p align="justify">
<br />
Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.
</p>
<p align="justify">
The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&quot;
</p>
<p align="justify">
Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&quot;
</p>
<p align="justify">
While Ranbaxy was &quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy's stakeholders,&quot; he added.
</p>
<p align="justify">
Specifically, federal prosecutors said Ranbaxy USA Inc.'s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government's allegations against Ranbaxy made &quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&quot;
</p>
<p align="justify">
Following several years of a federal investigation into Ranbaxy's alleged &quot;manufacturing deficiencies,&quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.
</p>
<p align="justify">
In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.
</p>
<p align="justify">
In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.
</p>',
		'credit_writer' => 'The Hindu, 15 May, 2013, http://www.thehindu.com/todays-paper/ranbaxy-fined-500-m-for-flawed-generics/article4716872.ece',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'ranbaxy-fined-500-m-for-flawed-generics-narayan-lakshman-21115',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 21115,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 20970,
	'metaTitle' => 'LATEST NEWS UPDATES | Ranbaxy fined $500 m for flawed generics-Narayan Lakshman',
	'metaKeywords' => 'medicines,generic drugs',
	'metaDesc' => '
-The Hindu



Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the...',
	'disp' => '<div align="justify">-The Hindu</div><p align="justify"><br />Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.</p><p align="justify">The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&quot;</p><p align="justify">Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&quot;</p><p align="justify">While Ranbaxy was &quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy's stakeholders,&quot; he added.</p><p align="justify">Specifically, federal prosecutors said Ranbaxy USA Inc.'s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government's allegations against Ranbaxy made &quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&quot;</p><p align="justify">Following several years of a federal investigation into Ranbaxy's alleged &quot;manufacturing deficiencies,&quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.</p><p align="justify">In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.</p><p align="justify">In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 20970,
	'title' => 'Ranbaxy fined $500 m for flawed generics-Narayan Lakshman',
	'subheading' => '',
	'description' => '<div align="justify">
-The Hindu
</div>
<p align="justify">
<br />
Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.
</p>
<p align="justify">
The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&quot;
</p>
<p align="justify">
Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&quot;
</p>
<p align="justify">
While Ranbaxy was &quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy's stakeholders,&quot; he added.
</p>
<p align="justify">
Specifically, federal prosecutors said Ranbaxy USA Inc.'s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government's allegations against Ranbaxy made &quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&quot;
</p>
<p align="justify">
Following several years of a federal investigation into Ranbaxy's alleged &quot;manufacturing deficiencies,&quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.
</p>
<p align="justify">
In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.
</p>
<p align="justify">
In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.
</p>',
	'credit_writer' => 'The Hindu, 15 May, 2013, http://www.thehindu.com/todays-paper/ranbaxy-fined-500-m-for-flawed-generics/article4716872.ece',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'ranbaxy-fined-500-m-for-flawed-generics-narayan-lakshman-21115',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 21115,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 20970
$metaTitle = 'LATEST NEWS UPDATES | Ranbaxy fined $500 m for flawed generics-Narayan Lakshman'
$metaKeywords = 'medicines,generic drugs'
$metaDesc = '
-The Hindu



Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the...'
$disp = '<div align="justify">-The Hindu</div><p align="justify"><br />Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.</p><p align="justify">The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company &quot;falsified drug data and systemically violated current good manufacturing practices and good laboratory practices.&quot;</p><p align="justify">Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the &quot;announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.&quot;</p><p align="justify">While Ranbaxy was &quot;disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy's stakeholders,&quot; he added.</p><p align="justify">Specifically, federal prosecutors said Ranbaxy USA Inc.'s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government's allegations against Ranbaxy made &quot;no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone.&quot;</p><p align="justify">Following several years of a federal investigation into Ranbaxy's alleged &quot;manufacturing deficiencies,&quot; the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants.</p><p align="justify">In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate.</p><p align="justify">In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Ranbaxy fined $500 m for flawed generics-Narayan Lakshman

-The Hindu Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S. The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came after whistleblower Dinesh Thakur, a former Ranbaxy director, wrote that eight years ago he discovered that the company "falsified drug data and systemically violated current good manufacturing practices and good laboratory practices." Arun Sawhney, CEO and Managing Director of Ranbaxy, said in a statement that the "announcement marks the resolution of this past issue. We are pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world." While Ranbaxy was "disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy's stakeholders," he added. Specifically, federal prosecutors said Ranbaxy USA Inc.'s guilty plea related to the Federal Food, Drug and Cosmetic Act, which prohibits the sale of impure drugs. Yet, reports noted that the government's allegations against Ranbaxy made "no claims that the drugs, whose strength, purity or quality differed from the specifications, harmed anyone." Following several years of a federal investigation into Ranbaxy's alleged "manufacturing deficiencies," the FDA, in 2008, banned the pharma giant from importing over 30 different drugs produced at Indian plants. In 2011, the U.S. insisted that Ranbaxy faced extra oversight and third-party review to strengthen its drug-making procedures, and ensured its product data was accurate. In bringing closure to the case, Ranbaxy was said to have admitted that it marketed adulterated medicines, including antibiotics and generic versions of drugs, to treat nerve pain, epilepsy and acne, developed at several manufacturing sites in India.